We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-2.58%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$210M
AUM Growth
+$11.3M
Cap. Flow
+$16.9M
Cap. Flow %
8.06%
Top 10 Hldgs %
36.19%
Holding
69
New
21
Increased
12
Reduced
17
Closed
15

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$9.56M
2
BMY icon
Bristol-Myers Squibb
BMY
+$6.83M
3
ELV icon
Elevance Health
ELV
+$6.69M
4
GILD icon
Gilead Sciences
GILD
+$5.95M
5
MCK icon
McKesson
MCK
+$5.15M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$7.8M
2
AMGN icon
Amgen
AMGN
+$7.51M
3
MDT icon
Medtronic
MDT
+$5.62M
4
GSK icon
GSK
GSK
+$5.39M
5
LLY icon
Eli Lilly
LLY
+$5.21M

Sector Composition

Rank Sector Weight
1 Healthcare 83.15%
2 Financials 3.55%
3 Industrials 1.31%
4 Consumer Staples 0.98%
5 Energy 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBB icon
1
iShares Biotechnology ETF
IBB
$9.34B
$9.29M 4.43%
+105,000
New +$9.56M
HUM icon
2
Humana
HUM
$43.7B
$7.83M 3.74%
38,382
-5,000
-12% -$954K
CELG
3
DELISTED
Celgene Corp
CELG
$7.81M 3.73%
67,500
-5,000
-7% -$557K
AET
4
DELISTED
Aetna Inc
AET
$7.44M 3.55%
60,000
+20,000
+50% +$2.39M
AZN icon
5
AstraZeneca
AZN
$263B
$7.38M 3.52%
135,000
+35,000
+35% +$1.99M
ALXN
6
DELISTED
Alexion Pharmaceuticals
ALXN
$7.34M 3.5%
60,000
– –
BMY icon
7
Bristol-Myers Squibb
BMY
$133B
$7.3M 3.49%
+125,000
New +$6.83M
UNH icon
8
UnitedHealth
UNH
$376B
$7.2M 3.44%
45,000
+10,000
+29% +$1.49M
ELV icon
9
Elevance Health
ELV
$81.5B
$7.19M 3.43%
+50,000
New +$6.69M
CNC icon
10
Centene
CNC
$30.7B
$7.06M 3.37%
250,000
+70,000
+39% +$2.07M
MRK icon
11
Merck
MRK
$322B
$6.77M 3.23%
120,520
-5,240
-4% -$307K
CI icon
12
Cigna
CI
$73.7B
$6.67M 3.18%
50,010
+5,010
+11% +$656K
REGN icon
13
Regeneron Pharmaceuticals
REGN
$78.5B
$6.42M 3.06%
17,500
+3,500
+25% +$1.33M
GILD icon
14
Gilead Sciences
GILD
$162B
$5.73M 2.73%
+80,000
New +$5.95M
BIIB icon
15
Biogen
BIIB
$30B
$5.67M 2.71%
20,000
– –
INCY icon
16
Incyte
INCY
$24.2B
$5.51M 2.63%
55,000
-5,000
-8% -$488K
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
$5.48M 2.62%
40,000
-5,000
-11% -$637K
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.6B
$4.97M 2.37%
60,000
-10,000
-14% -$860K
MCK icon
19
McKesson
MCK
$100B
$4.92M 2.35%
+35,000
New +$5.15M
MOH icon
20
Molina Healthcare
MOH
$10.2B
$4.88M 2.33%
90,000
+10,000
+13% +$547K
BCR
21
DELISTED
CR Bard Inc.
BCR
$4.49M 2.14%
+20,000
New +$4.35M
BDX icon
22
Becton Dickinson
BDX
$45.6B
$4.14M 1.97%
25,625
+2,562
+11% +$425K
JNJ icon
23
Johnson & Johnson
JNJ
$618B
$4.03M 1.92%
35,000
-25,000
-42% -$2.89M
COR icon
24
Cencora
COR
$60.6B
$3.91M 1.87%
+50,000
New +$3.9M
BSX icon
25
Boston Scientific
BSX
$69.5B
$3.79M 1.81%
175,000
-25,000
-13% -$545K
1
2 3

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
FF
Fairway Financial Casselberry, Florida $132M AUM 13.23% 1-Year Est. Return
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM

Sivik Global Healthcare's Q4 2016 Portfolio in Review

As of Q4 2016, Sivik Global Healthcare held 69 positions worth $210M, up 5.7% from $198M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sivik Global Healthcare deployed $16.9M of net new capital in Q4 2016, opening 21 new positions and adding to 12 existing holdings. Its largest new stake was iShares Biotechnology ETF: 105,000 shares worth $9.29M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 91% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $5.21M trimmed.

  • Sivik Global Healthcare's largest Q4 2016 buy was iShares Biotechnology ETF: 105,000 shares worth $9.29M.
  • Sivik Global Healthcare added most to Aetna Inc in Q4 2016, an estimated $2.39M increase.
  • Sivik Global Healthcare's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $5.21M.
  • Sivik Global Healthcare fully exited Zimmer Biomet in Q4 2016, selling an estimated $7.8M.
  • Sivik Global Healthcare's ten largest holdings make up 36% of its $210M portfolio in Q4 2016.
  • Sivik Global Healthcare opened 21 new positions and closed 15 in Q4 2016.
  • Sivik Global Healthcare's portfolio value rose 5.7% quarter-over-quarter to $210M.

Based on Sivik Global Healthcare's 13F filing for Q4 2016, filed 13 Feb 2017.